TY - JOUR
T1 - Efficacy of predetermined therapeutic measures against bleb-related infection in the Collaborative Bleb-related Infection Incidence and Treatment Study
AU - the Collaborative Bleb-Related Infection Incidence and Treatment Study Group
AU - Shoji, Nobuyuki
AU - Arakaki, Yoshikuni
AU - Nakamoto, Kenji
AU - Yamamoto, Tetsuya
AU - Kuwayama, Yasuaki
AU - Aoyama, Yumiko
AU - Kawase, Kazuhide
AU - Ban, Takahiro
AU - Sawada, Akira
AU - Mochizuki, Kiyofumi
AU - Futa, Ryusuke
AU - Yasuda, Noriko
AU - Nakajima, Masayuki
AU - Sugiyama, Tetsuya
AU - Kojima, Shota
AU - Hirotsuji, Norihiko
AU - Kano, Kiyoshi
AU - Ohura, Atsushi
AU - Kawai, Eriko
AU - Nakata, Atsuko
AU - Kuwamura, Rika
AU - Okuno, Kensuke
AU - Yawata, Kenji
AU - Matsumoto, Shun
AU - Abe, Haruki
AU - Fukuchi, Takeo
AU - Shirakashi, Motohiro
AU - Ueda, Jun
AU - Tanaka, Takayuki
AU - Negi, Akira
AU - Nakamura, Makoto
AU - Kanamori, Akiyasu
AU - Yamada, Yuko
AU - Tawara, Akihiko
AU - Kubota, Toshiaki
AU - Tou, Norihiko
AU - Kimura, Tairo
AU - Furusawa, Chiaki
AU - Inoue, Naoki
AU - Kawabata, Kiho
AU - Tachibana, Nobuhiko
AU - Matsuda, Akira
AU - Seto, Takahiko
AU - Kimura, Satoshi
AU - Ueno, Satoki
AU - Tokuda, Naoto
AU - Inoue, Jun
AU - Sugiyama, Kazuhisa
AU - Ohkubo, Shinji
AU - Yuki, Kenya
N1 - Publisher Copyright:
© 2017 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd
PY - 2018/3
Y1 - 2018/3
N2 - Purpose: To report the efficacy of the predetermined treatment protocol of the Collaborative Bleb-related Infection Incidence and Treatment Study (CBIITS) for bleb-related infection (BRI) patients. Methods: A prospective, observational cohort study was conducted at 34 clinical centres in Japan. Nineteen eyes from 19 patients that developed BRI were treated using the CBIITS protocol at 34 clinical centres. The visual acuity (VA) and intraocular pressure (IOP) were monitored for 6 and 12 months after treatment with the predetermined protocol. Results: The logMAR was 0.623 ± 0.748 (mean ± standard deviation) before the infection developed. It was 1.054 ± 1.156 and 0.950 ± 1.168 at 6 months and 12 months post-infection, respectively. However, in subgroup analyses, there was no significant decrease in post-infection logMAR in stages I and II. In contrast, decimal VA was decreased ≥2 lines in all four cases in stage III. The IOP did not change after infection. It was 10.2 ± 5.0 mmHg (range, 3–22 mmHg) before the infection developed, and 12.9 ± 5.2 mmHg (5–24 mmHg) and 10.7 ± 4.7 mmHg (3–18 mmHg) at 6 months and 12 months after infection, respectively. Conclusion: Because of the small number of BRI patients, the superiority of the treatment was not definitively determined. However, VA was almost maintained in stages I and II, and the IOP did not change after infection. Although further study is necessary, the treatment protocol shown in the study might be a valuable treatment regime.
AB - Purpose: To report the efficacy of the predetermined treatment protocol of the Collaborative Bleb-related Infection Incidence and Treatment Study (CBIITS) for bleb-related infection (BRI) patients. Methods: A prospective, observational cohort study was conducted at 34 clinical centres in Japan. Nineteen eyes from 19 patients that developed BRI were treated using the CBIITS protocol at 34 clinical centres. The visual acuity (VA) and intraocular pressure (IOP) were monitored for 6 and 12 months after treatment with the predetermined protocol. Results: The logMAR was 0.623 ± 0.748 (mean ± standard deviation) before the infection developed. It was 1.054 ± 1.156 and 0.950 ± 1.168 at 6 months and 12 months post-infection, respectively. However, in subgroup analyses, there was no significant decrease in post-infection logMAR in stages I and II. In contrast, decimal VA was decreased ≥2 lines in all four cases in stage III. The IOP did not change after infection. It was 10.2 ± 5.0 mmHg (range, 3–22 mmHg) before the infection developed, and 12.9 ± 5.2 mmHg (5–24 mmHg) and 10.7 ± 4.7 mmHg (3–18 mmHg) at 6 months and 12 months after infection, respectively. Conclusion: Because of the small number of BRI patients, the superiority of the treatment was not definitively determined. However, VA was almost maintained in stages I and II, and the IOP did not change after infection. Although further study is necessary, the treatment protocol shown in the study might be a valuable treatment regime.
KW - bleb-related infection
KW - blebitis
KW - predetermined treatment protocol
KW - trabeculectomy
UR - http://www.scopus.com/inward/record.url?scp=85033486488&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85033486488&partnerID=8YFLogxK
U2 - 10.1111/aos.13523
DO - 10.1111/aos.13523
M3 - Article
C2 - 29115726
AN - SCOPUS:85033486488
SN - 1755-375X
VL - 96
SP - e229-e236
JO - Acta Ophthalmologica Scandinavica
JF - Acta Ophthalmologica Scandinavica
IS - 2
ER -